Novartis AG - H5820Q150
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | History | Reduced | 23,292 | 3,344 | 0.11% | 0.13% | 1 | -1,043 | -4.29% | Q3 2026 | Nov 16, 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | History | No change | 15,729 | 2,463 | 0.12% | 0.12% | 2 | 0 | 0.0% | Q3 2026 | Oct 15, 2026 |